Ceribell (CBLL) Notes Payables (2023)
Ceribell (CBLL) posted Notes Payables of $11.8 million for Q4 2023.
Ceribell (CBLL) Notes Payables (2023) Analysis & Trends
Ceribell's Notes Payables history runs 1 years deep, the most recent figure standing at $11.8 million for Q4 2023.
- Quarterly Notes Payables changed N/A year-over-year to $11.8 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $11.8 million (changed N/A YoY) and the FY2023 annual result came in at $11.8 million, changed N/A from the prior year.
- Notes Payables was $11.8 million for Q4 2023 at Ceribell.
- Across five years, Notes Payables topped out at $11.8 million in Q4 2023 and bottomed at $11.8 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn |
| 10 | Ceribell | 672.48 Mn | 531.29 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 11.83 Mn |